Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Shareholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / February 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of STAAR Surgical Company ("STAAR" or "the Company") . Investors who purchased STAAR securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/STAA.Investigation DetailsOn February 11, 2025, STAAR issued a press release reporting its financial results for the fourth quarter and full year 2024. Among other items, for the quarter, STAAR reported GAAP earnings per share of -$0.69, missing consensus estimates by $0.55, and revenue of $48.95 million, missing consensus estimates by $28.52 million. The Company attributed its results to "fluctuating demand in China". On this news, STAAR's stock price fell $5.40 per share, or 24.68%, to close at $16.48 per share on February 12, 2025.What's Next?If you are aware of any facts relating to this investigation or purchased STAAR securities, you can assist this investigation by visiting the firm's site: bgandg.com/STAA. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: There is No Cost to YouWe represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.Why Bronstein, Gewirtz & GrossmanBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.Follow us for updates on LinkedIn, X, Facebook, or Instagram.Attorney advertising. Prior results do not guarantee similar outcomes.ContactSOURCE: Bronstein, Gewirtz & Grossman, LLCView the original press release on ACCESS Newswire